Trade IKT stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Inhibikase Therapeutics, Inc. (IKT) is trading at US$2.41, down 0.82% today as of Sep 9, 16:00 EDT. The company has a market capitalisation of US$333.49M. Over the past 52 weeks, IKT has traded between US$1.33 and US$2.61. On Syfe you can trade IKT with $0 commission and add it to your watchlist.
| Previous close | US$2.43 |
|---|---|
| Market cap | US$333.49M |
| 52-week range | US$1.33 – US$2.61 |
| Volume | 323.43K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Inhibikase Therapeutics, Inc.
Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in development of protein kinase inhibitor therapeutics to modify the course of Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. It also focuses on neurodegeneration and its lead program IkT-148009, an Abelson Tyrosine Kinase (c-Abl) inhibitor, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Ableson Tyrosine Kinases. The company was founded by Milton H. Werner in September 2008 and is headquartered in Wilmington, DE.
Year: 2020
Inhibikase Therapeutics Wins US FDA Orphan Drug Status for IKT-001 in Pulmonary Arterial Hypertension
Jul 23, 12:42 PM · MT Newswires
Oppenheimer Initiates Inhibikase Therapeutics at Outperform
Jun 10, 10:53 AM · MT Newswires
Inhibikase Therapeutics Enrolls First Patient In Phase 3 Trial For Pulmonary Arterial Hypertension
Apr 7, 1:14 PM · MT Newswires
Inhibikase Therapeutics, Inc. (IKT) stock is trading at US$2.41, -0.82% from the previous close of US$2.43.
The market cap for Inhibikase Therapeutics, Inc. (IKT) stock is approximately US$333.49M.
The 52-week high for Inhibikase Therapeutics, Inc. (IKT) stock is US$2.61.
The 52-week low for Inhibikase Therapeutics, Inc. (IKT) stock is US$1.33.
Inhibikase Therapeutics, Inc. (IKT) does not currently pay a dividend.
Stay on top of IKT
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
